18 April 2019, Thursday
HALL 1 HALL 2 HALL 3
OPENING CEREMONY
   
OPENING CONFERENCE
Chair: Brian Leonard (Ireland)

Using Brain-based Phenotyping to Improve Discovery in Psychiatry
Carol Tamminga (USA)
   
SYMPOSIUM 1
Advancing Psychiatric Diagnosis And Therapeutics Using Artificial Intelligence (AI)
Moderators: Andrew Greenshaw (Canada), Marek Kubicki (USA)

AI in Psychiatry: Relevance of successful aging indicators
Bo Coa


AI and schizophrenia - current and future prospects
Ezgi İnce Guliyev


AI solutions for Bipolar Disorder: natural language and face recognition
Elvan Çiftçi
PLENARY LECTURE 1

The inside out of the outside within: a role for epigenetics in mental disorder

Bart Rutten (Netherlands)
PLENARY LECTURE 2

The development, determinants and treatment of psychopathology in offspring of patients with bipolar disorder

Mannon Hillegers (Netherlands)
SYMPOSIUM 4
Neuroplasticity of the brain: Evidence and Management
Moderators: Carol Tammigna (USA), Ali Saffet Gönül

fMRI and Alcohol use Disorder
Michal Juhas (Canada)


How does depression affect the brain during adolescence?
Ali Saffet Gönül


Low field magnetic stimulation as a new neuroprotective approach for neuropsychiatric disorders: evidence from animal studies
Yanboo Zhang (Canada)


rTMS in psychiatry practice
Abdullah Bolu
SYMPOSIUM 5
A special but comprehensive review in addiction
Moderators: Mücahit Öztürk(TAP), Kültegin Ögel

New psychopharmacological treatments in addiction
Cüneyt Evren


Community-based approach to addiction treatment
Kültegin Ögel


The concept of rehabilitation in addiction
Rabia Bilici


Effective psychosocial in the treatment of addiction
Melike Şimşek
PLENARY LECTURE 4

Childhood anxiety disorders: Into adolescence and adulthood, diagnosis and difficulties in treatment

Bengi Semerci (TAP)
19 April 2019, Friday
HALL 1 HALL 2 HALL 3
WORKSHOP 2
Treatment approaches in psychiatric symptoms in Alzheimer's disease patients
Işın Baral Kulaksızoğlu
  WORKSHOP 4
Development and Well-Being Assessment

A Diagnostic Interview for Child and Adolescent Mental Disorders
Onur Burak Dursun (TAP)
SYMPOSIUM 9
Recent advances in mood disorders: neurobiology, technology, and biomarkers
Moderators: Feyza Aricioglu(TAP), Kyooseob Ha(South Korea)

Future of psychiatry: role of technology for depression
Xin-Min Li (Canada)


Development of multiple proteomic marker panel and predictive model for the onset and progress of mood disorders
Kyooseob Ha (South Korea)

Neurobiology of mood disorders focusing on neuroinflammation and future treatment strategies
Feyza Aricioglu (TAP)


Clinical implication of current brain image findings in bipolar disorder
, Yuan-Hwa Chou (Taiwan)
PLENARY LECTURE 5
Chairs: Kürşat Altınbaş, Çiğdem Şahbaz
Psychosis spectrum disorder: From the genome to the exposome and to the phenome
Sinan Gülöksüz (Netherlands)
PLENARY LECTURE 6
Chairs: Kerim Munir (USA), Ibrahim Durukan

Developmental Coordination Disorder and its implication on treatment of ADHD and ASD
Yankı Yazgan
PLENARY LECTURE 7
Chairs: Kültegin Ögel, Kemal Sayar (TAP)

Problematic smartphone use and relations with psychopathology constructs
Jon Elhai (USA)
SYMPOSIUM 12
Diagnostic and Therapeutic Advances in Later in Life Neuropsychiatry
Moderators: Işın Baral Kulaksızoğlu, Weihong Song (Canada)

Early Recognition and Diagnosis of Neuropsychiatric Disorders in Dementia; An overview
Işın Baral Kulaksızoğlu


Artificial Intelligence to advance neuroscience of normal or abnormal aging Process
Bo Cao (Canada)


ADHD as a later in life Neuropsychiatric Disorder?
Bahadır Turan


Advances in the therapeutics of Dementia?
Weihong Song (Canada)
SYMPOSIUM 13
Principles and Advances in Stem Cell Therapy in Neuropsychiatric Disorders
Moderators: Erdem Tüzün

Psychiatric disease modeling by organoids through stem cells
Özge Sezin Somuncu


Recent Advances in Stem Cell-Based Therapeutics for Neurodegenerative Diseases
Erdem Tüzün


Clinical Implications of Stem Cell as Therapeutic Targeting in Schizophrenia and Other Psychotic Disorders
Ümit Haluk Yeşilkaya
PLENARY LECTURE 8
Chairs: Serdar Dursun (Canada) (TAP), Dost Öngür (USA)

Hippocampal pathology and its contribution to psychosis in schizophrenia
Carol Tamminga (USA)
SPECIAL SYMPOSIUM 2
Sadness, Depression, Emotions and Drugs
Moderators: Erol Göka

Emotion, Temperament and Mood
Erol Göka


Sadness, the most appropriate to us: inducing sadness, consuming depression
Murat Beyazyüz


Treatment-resistant depression, depression-resisting psychiatry
Hasan Kaya
PLENARY LECTURE 9
Chairs: Özgür Öner, Feyza Aricioglu (TAP)

Stress, glucocorticoids and memory: implications for treating fear-related disorders
Benno Roozendaal (Netherlands)
DOUBLE CONFERENCE
Psychiatry in the brain age
Moderators: Erol Göka, Serdar Dursun (Canada) (TAP)

Psychiatry between the brain and mind
Kazım Yazıcı


Does the brain explain everything? Neuromania and psychiatry
Kemal Sayar (TAP)
SYMPOSIUM 20
Paradigm shift in psychiatric neuroimaging studies
Moderators: Fei Wang (China),Yanqing Tang (China)

Diffusion MRS techniques and white matter biology in schizophrenia
Dost Öngür (USA)


Dopamine transporter and hippocampal volumes in schizophrenia
Yuan-Hwa Chou (Taiwan)


How analyzing big imaging data can help understanding time course of white matter pathology in schizophrenia
Marek Kubicki (USA)


The effects of emotions on learning in depressed patients: an fMRI study
Ali Saffet Gönül
SYMPOSIUM 21
Evidence based treatments in autism spectrum disorders
Moderators: Kerim Munir (USA), Onur Burak Dursun (TAP)

Evidence based treatment of challenging behaviors in ASD
Özgür Öner


Questions of severity, specifiers, and treatment challenges in complex autism spectrum disorders
Kerim Munir (USA)


Evidence based therapies and non-medical treatments in ASD
Carmen Aparicio Samsunlu


Non-evidence based fad treatments
Ayşegül Efe
SYMPOSIUM 25
Cannabis Use: Global Perspectives 360°
Moderators: Kültegin Ögel, Mihriban Heval Özgen (Netherlands)

Cannabis Use and Regulations in Netherlands; "Amsterdam Cannabis Cafes and the Dutch Experience"
Mihriban Heval Özgen (Netherlands)


Cannabis use and Recent Regulations in Canada
Serdar Dursun (Canada) (TAP)


Course of cannabis use in Turkey and contribution of cannabidiol to treatment
Cüneyt Evren


Cannabis, harm reduction or total abstinence: Implications for Society, Law and health
Andrew Greenshaw (Canada)

SYMPOSIUM 26
Cognition and Perception In Psychotic Disorders: New Perspectives
Moderators: Dost Öngür (USA), Serhat Çıtak (TAP)

Visual perception deficits in psychotic disorders and their potential as neurobiological markers
Halide Bilge Turkozer (USA)


Language and gesture in schizophrenia spectrum
Hale Yapici Eser

COURSE 11
The definition and treatment of treatment-resistant depression
Ali Saffet Gonul
20 April 2019, Saturday
HALL 1 HALL 2 HALL 3
WORKSHOP 7
Increasing productivity and efficiency in primary data manuscript writing
Jon Elhai (USA)
WORKSHOP 8
Animal Models in Translational Research on Stress-Related Disorders
Benno Roozendaal(Netherlands)
SYMPOSIUM 29
A New Disorder That Comes With Technology Age: Internet Addiction
Moderators: Mücahit Öztürk (TAP), Onur Burak Dursun (TAP)

Is Internet Addiction a Clinical Diagnosis?
Gül Karaçetin


Epidemiology and Neurobiology of Internet Addiction
Caner Mutlu


Psychosocial Factors in Internet Addiction
Mehmet Tekden


Treatment of Internet Addiction
Erdem Örnek
  SYMPOSIUM 30
Complementary, integrative and culture-based treatments in psychiatry
Moderators: Mesut Çetin (TAP), Xin-Min Li (Canada)

Herbal and complementary therapies in Mediterranean countries
Feyza Aricioglu (TAP)


MDMA (Ecstasy) enhanced psychotherapy in PTSD: review of the evidence
Mihriban Heval Ozgen (Netherlands)


The research and application of acupuncture therapy in depression
Yanqing Tang (China)


South American based complementary treatments in psychiatry and ayahuasca
Andrew Greenshaw(Canada)
SYMPOSIUM 31
Approach to Autism Spectrum Disorders (ASD): New developments/new treatments
Moderators: Özalp Ekinci, Ayse Rodopman Arman

Signs and symptoms of destructive behaviour in ASD and approach to treatment
Ozalp Ekinci


Signs of anxiety and approach to quality of life in ASD
Serkan Güneş
SYMPOSIUM 35
Personalized psychopharmacology: are we ready to implement it?
Moderators: Angelos Halaris (USA), Brian Leonard (Ireland)

Neuroprogression in psychiatric disorders
Angelos Halaris (USA)


Targeted pharmacological interventions to arrest neuroprogression
Brian Leonard (Ireland)


C-reactive protein: Are we ready to introduce it into clinical practice?
Danika Prochaska (USA)


Pharmacogenomics in psychiatric practice: What it can do for us
Katherine Johnson (USA)
PLENARY LECTURE 11
New approaches for psychiatric treatments: From Theory to Practice
Chairs: Dost Öngür (USA), Mesut Çetin (TAP)

- Ketamine for TRD; 360° review
- Nitropurisside for TR Schizophrenia

Serdar Dursun (Canada) (TAP)
PLENARY LECTURE 12
Chairs: Mücahit Öztürk(TAP), Burak Baykara

Comorbidity of Mental Disorders in Individuals with Intellectual Disabilities/Intellectual Developmental Disorders: Services and Gaps in Care
Kerim Munir (USA)
DEBATE
Is psychodynamic psychotherapy or cognitive behavioral therapy effective in the treatment of depression and anxiety disorders?
Chairs:Erol Göka, Hayrettin Kara

OPPONENT :
Cognitive behavioral therapy is more effective in the treatment of depression and anxiety disorders.
Hakan Türkçapar (TAP)


PROPONENT :
Psychodynamic therapy is more effective in the treatment of depression and anxiety disorders.
Serhat Çıtak (TAP)
SPECIAL SYMPOSIUM
RATIONAL DRUG USE SYMPOSIUM
Chairs:Kemal Sayar (TAP), Mücahit Öztürk (TAP)

Is psychiatry at a crossroads in terms of treatment interventions? What should be done besides pharmacotherapy and psychotherapies for effective treatment of psychiatric disorders?
Mesut Çetin (TAP)


Prevention also matters for rational drug use: Tier 1 Services and Current Mental Health Prevention Efforts of the Turkish Ministry of Health
Esra Alataş
SYMPOSIUM 40
Speech and language in childhood psychopathologies
Moderators:Elvan İşeri, Koray Karabekiroğlu

Delayed language development: diagnostic and therapeutic approach to the related disorders
Sema Acar


Language and mind in the context of atypical autism
Koray Karabekiroğlu


ADHD and speech and language disorders
Saliha Baykal
SYMPOSIUM 44
How to transform basic neurobiology into psychiatric practice
Moderators:Andrew Greeshaw (Canada), Kazım Yazıcı

Functional restoration of the brain: White matter matters
Jiming Kong (Canada)


Low field magnetic stimulation as a new neuroprotective approaches for neuropsychiatric disorders: evidence from animal studies
Yanbo Zhang (Canada)


Synaptic plasticity in in ketamine’s anti-depressive effects
Yu Tian Wang (Canada)


Biomaker studies on psychosis
Tao Li (China)
PLENARY LECTURE 13
Chairs: Yasemen Işık Taner, Onur Burak Dursun (TAP)

The genesis of artistic creativity. Genius genes and autism
Michael Fitzgerald (Ireland)
SYMPOSIUM 45
A novel dream model for psychotherapies: Phenomenological Dream Self Model (PDSM)
Moderators: Hayrettin Kara

Psychotherapy, dreams, and theoretical basis of PDSM
Hayrettin Kara


Current neuroscience and PDSM studies about dreams
Sena Yenel


General framework of PDSM: process and technique
Feyza Bağlan
FORUM
An international dialogue of collaboration in research: What can we do?
Moderators: Kemal Sayar(TAP), Serdar Dursun (Canada)(TAP)

Opportunities in mental health research at University of Alberta
Xin-Min Li (Canada)


Regional and international collaboration for bipolar disorders: EABF, ANBD, and ISBD
Kyooseob Ha (South Korea)


Potential for multi-site translational research in psychiatry – what are the pitfalls?
Dost Öngür (USA)


International collaboration on using neuroimaging to investigate trajectories of brain changes in schizophrenia
Ali Saffet Gönül
SYMPOSIUM 49
Evaluation of psychotropic medication related problems in pediatric inpatients
Moderators: Ebru Cengel Kultur, Neslihan Emiroglu

Clinical pharmacy practices and drug related problems
Kutay Demirkan


Psychopharmacology and polypharmacy
Nadir Yalcin


Psychotropic-psychotropic & Psychotropic-drug interactions: Which one is more important in child and adolescent psychiatry?
Halime Tuna Cak Esen


Drug-drug interaction of psychotropic drugs with off-label usage
Nesligul Ozdemir
SYMPOSIUM 50
Neuropsychiatric disorders and physical diseases multidisciplinary approach
Moderators: Neşe Kocabaşoğlu, Bülent Bahçeci

The importance of exercise in mental disorders
Selim Polat


Exercise prescriptions in neurological diseases
Tuğba Uyar


Exercise therapy in children and adolescent mental disorders
Selcen Esenyel
AWARD CEREMONY
21 April 2019, Sunday
HALL 1 HALL 2 HALL 3
SYMPOSIUM 54
Current approaches to nicotine abuse
Moderators: İbrahim Taymur, Neşe Kocabaşoğlu

Neurobiology of nicotine (cigarette) abuse disorder
Ayşegül Kervancıoğlu 


Pharmacotherapy in nicotine (cigarette) abuse disorder
Bengü Yücens 


Cognitive behavior in nicotine (cigarette) abuse disorder psychotherapy
Canan Efe 


Hypnosis in nicotine (cigarette) abuse disorder
Ayşegül Kart 
  SYMPOSIUM 56
Complementary treatments in management of ADHD
Moderators: Onur Burak Dursun (TAP), İbrahim Selçuk Esin

Contribution of neuro- and bio-feedback in treatment of ADHD
İbrahim Selçuk Esin 


Contribution of ergotherapy in treatment of ADHD
Hicran Doğru 


Contribution of family-based approaches in treatment of ADHD
Bahadır Turan 


Contribution of supplements in treatment of ADHD
İlknur Ucuz 
SYMPOSIUM 60
Recent studies in the field of bipolar disorder
Moderators: Özge Şahmelikoğlu Onur

Biological and clinical markers in bipolar disorder
Suat Yalçın 


Neuroimaging findings in bipolar disorder
Büşra Güney 


Cognitive functions in bipolar disorder
Pelin Özkara Menekşeoğlu


Metacognitions in Bipolar Disorder
Gülşen Teksin Ünal 
SYMPOSIUM 61
Management of treatment-resistant cases in child and adolescent psychiatry
Moderators: Ayten Erdoğan, Oğuzhan Zahmacıoğlu

Approach to management of disruptive behavior associated with ASD and mental retardation who are unresponsive to standard treatments
Ayten Erdoğan


Approach to ADHD patients who are unresponsive to standard treatments
Sevcan Karakoç Demirkaya 


Are starting herbal treatment? Heightened doubt/mistrust as an indicator of treatment resistance in the age of information
Oğuzhan Zahmacıoğlu 


Psychotherapies in treatment of PTSD unresponsive to medications
Hale Kahyaoğlu 
SYMPOSIUM 62
Sluggish cognitive tempo: Different aspects and differential diagnosis of an underrecognized psychiatric situation
Moderators:F.Sibel Durak, İlknur Ucuz

Slow in motion, slow in cognition, slow in organizing, slow in everything ; What is sluggish cognitive tempo?
Ayşe Kutlu 


What is happening in the brain of children with sluggsih cognitve tempo? Neurocognitive aspects of sluggish cognitive tempo?
Nagihan Cevher Binici


Biological evidence of a distinct clinical entity: Sluggish cognitive tempo?
Gül Ünsel Bolat


Ongoing debates of sluggish cognitive tempo and possible treatment options
Sevay Alşen Güney
CLOSING REMARKS